Jump to content
  • Our Mission Pooling competencies – pushing innovations

    BIOPRO Baden-Württemberg GmbH supports the medical technology, biotechnology and pharmaceutical sectors in the healthcare industry as well as the development of a bioeconomy in Baden-Württemberg.

  • Healthcare industry BW Industry report

    We track the economic performance of companies actively engaged in biotechnology, medical technology and pharmaceutical industry. Our publications provide the latest facts und figures for Baden-Württemberg’s healthcare industry.

  • Bioeconomy BW Towards greater sustainability

    We support regional bioeconomic strategies to promote and strengthen sustainability objectives in Baden-Württemberg. These strategies include regional research and development capacities, analyse approaches for circular economy and aim at the establishment of interfaces to both internal and external partners.

Latest news

The European Start-up Community meets Baden-Württemberg

Stuttgart
Summit

The next Start-up BW Summit will take place on 23 and 24 July 2020 and is currently in the planning stage. Baden-Württemberg has a lot to offer for founders and start-ups. The entire diversity of Baden-Württemberg's start-up landscape will be on display at the Start-up BW Summit on July 23 and 24, 2020.


New on ...

... Healthcare industry BW

The CRISPR-Cas gene-editing technology is one of the most important developments in molecular biology in recent years. It utilises molecular scissors with which nucleic acids can be cut and edited almost arbitrarily. Researchers in Freiburg, Germany have now successfully used the technology for diagnostic purposes. They are currently working intensively on expanding the system to enable it to detect genome sequences of the novel SARS-CoV-2 virus.

... Healthcare industry BW

There is currently no cure for multiple sclerosis, the most common neurological autoimmune disease in humans. Biopharmaceuticals that can delay the course of the disease or diminish its effects are often prevented from being fully effective by the blood-brain barrier. A European consortium led by the Fraunhofer IGB, Stuttgart is developing a new technology that can transport an innovative active ingredient directly to the central nervous system.

... Healthcare industry BW

Researchers around the world are working frantically on the development of a vaccine against the new coronavirus. A project by the Tübingen-based biotechnology company CureVac, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), uses the company’s technology platform for mRNA-based vaccines to accelerate vaccine development, thus contributing to the future prevention of the disease.

... Bioeconomy in BW

Sensor networks are one of the keys to achieving digitalisation of the bioeconomy. Sensor networks are on the way to becoming important analysis and control instruments for energy-efficient and sustainable material cycles. Dieter Hertweck, Professor of Business Information Systems at Reutlingen University of Applied Sciences, shows what is already possible in digital agriculture and waste recycling and what is feasible for the future.

... Bioeconomy in BW

Lentils were once considered poor man’s food, but in Germany demand for them has never been greater1. And to satisfy this growing demand, more lentils need to be cultivated. This is why the University of Hohenheim is involved in the EIP-AGRI "Rhizo-Linse" project. The aim of the project is to find rhizobia strains that go well with lentil plants to increase yield and improve quality.

... Bioeconomy in BW

Decentralised, controllable and stable - renewable energy is an important component in the transition to a bioeconomy without fossil fuels. BIOPRO spoke to PD Dr. Andreas Lemmer from the State Institute of Agricultural Engineering and Bioenergy at the University of Hohenheim and Prof. Dr. Stefan Pelz, scientific director of the Institute for Applied Research and professorat the University of Applied Forest Sciences Rottenburg.

Website address: https://www.bio-pro.de/en